Shanghai Liu

Dr. Shanghai Liu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2023 in Biology
Verified
Journal Article
Open access
PDF file
HTHaoyi Tang
Haoyi Tang
SLShanghai Liu
Shanghai Liu
XYXiangyu Yan
Xiangyu Yan
YJYusheng Jin
Yusheng Jin
XHXiangyang He
Xiangyang He
AWAnqing Wu
Anqing Wu
Lung cancer remains the leading cause of cancer-related deaths in both women and men, claiming millions of lives worldwide. Radiotherapy is an effective modality for treating early-stage lung cancer; however, it cannot completely eradicate certain tumor cells due to their radioresistance. Radioresistance is commonly observed in conventionally fractionated radiotherapy, which can lead to treatment failure, metastasis, cancer recurrence, and poor prognosis for cancer patients. Identifying the underlying molecular mechanisms of radioresistance in lung cancer can promote the development of effective radiosensitizers, thereby improving patients’ life expectancy and curability. In this study, we identified LNC EBLN3P as a regulator of lung cancer cell proliferation and radiosensitivity. The repression of LNC EBLN3P could increase ROS production and mitochondrial injury in NSCLC cells. In addition, knocking down LNC EBLN3P increased the binding of Nrf2 to Keap1, resulting in enhanced Nrf2 degradation, decreased translocation of Nrf2 to the nucleus, reduced expression of antioxidant protein HO-1, weakened cellular antioxidant capacity, and increased radiosensitivity of NSCLC cells. These findings suggest that targeting LNC EBLN3P could be a promising strategy for developing novel radiosensitizers in the context of conventional radiotherapy for NSCLC.

14 March 2026 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SLShanghai Liu
Shanghai Liu
XHXinyu Hu
Xinyu Hu
RTRuizhan Tong
Ruizhan Tong
JYJiaxi Yan
Jiaxi Yan
RJRuiyi Jiang
Ruiyi Jiang
YLYou Lu
You Lu